Vericel (VCEL) Capital Expenditures (2010 - 2026)

Vericel (VCEL) reported Capital Expenditures of $1.3 million for Q1 2026, down 91.16% on a YoY basis from $14.2 million in Q1 2025, and down 95.17% sequentially from $26.0 million in Q4 2025.

Vericel (VCEL) Capital Expenditures (2010 - 2026) Analysis & Trends

Vericel (VCEL) has 16 years of Capital Expenditures data on file, last reported at $1.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Capital Expenditures fell 91.16% year-over-year to $1.3 million; the trailing twelve-month figure through Mar 2026 stood at $14.2 million (up 1.51% YoY), and the FY2025 full-year result was $27.2 million, up 128.29% from the prior year.
  • Capital Expenditures fell to $1.3 million in Q1 2026, from $26.0 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $26.0 million in Q4 2025 to a low of -$38.3 million in Q4 2024.
  • A 5-year average of $3.4 million and a median of $3.1 million in 2022 frame the typical range for Capital Expenditures.
  • Peak annual rise in Capital Expenditures reached 1456.46% in 2024, while the deepest fall reached 935.27% in 2024.
  • Tracing VCEL's Capital Expenditures over 5 years: stood at $7.3 million in 2022, then plunged by 37.56% to $4.6 million in 2023, then slumped by 935.27% to -$38.3 million in 2024, then surged by 167.99% to $26.0 million in 2025, then tumbled by 95.17% to $1.3 million in 2026.
  • Business Quant data shows VCEL's Capital Expenditures at $1.3 million in Q1 2026, $26.0 million in Q4 2025, and -$21.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -8,939.03
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 43.25 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 133.40 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 230.60 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 786,000.00
10 Vericel 2.30 Bn 2.15 Bn 49.27 Mn 1.26 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.26 Mn
Mar 31, 2026 1.26 Mn
Dec 31, 2025 26.03 Mn
Dec 31, 2025 26.03 Mn
Sep 30, 2025 -21.22 Mn
Sep 30, 2025 -21.22 Mn
Jun 30, 2025 8.13 Mn
Jun 30, 2025 8.13 Mn
Mar 31, 2025 14.21 Mn
Mar 31, 2025 14.21 Mn
Dec 31, 2024 -38.29 Mn
Dec 31, 2024 -38.29 Mn
Sep 30, 2024 19.41 Mn
Sep 30, 2024 19.41 Mn
Jun 30, 2024 18.66 Mn
Jun 30, 2024 18.66 Mn
Mar 31, 2024 12.12 Mn
Mar 31, 2024 12.12 Mn
Dec 31, 2023 4.58 Mn
Dec 31, 2023 4.58 Mn